# Innogen Pharmaceuticals Enters into Licensing Agreement with Arcera Life Sciences for Efsubaglutide Alfa, Accelerating International Expansion

- Source: PR Newswire M&A
- Published: 2026-11-19T10:05:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/innogen-pharmaceuticals-enters-into-licensing-agreement-with-arcera-life-sciences-for-efsubaglutide-alfa-accelerating-international-expansion-302945265.html
- Canonical: https://groundlevelnews.com/story/innogen-pharmaceuticals-enters-into-licensing-agreement-with-arcera-li-f3f948/

Under the agreement, Arcera will obtain exclusive rights to Efsubaglutide Alfa in selected countries in Africa, Latin America, the Middle East and Eastern Europe, while Innogen retains the relevant rights in the rest of the world. Under the agreement, Innogen will receive US$38 million in...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
